Aggressive Multi-Modality Treatment of Pancreatic Neuroendocrine Tumors (pNETs): Outcomes in Patients with Advanced Disease

#1144

Introduction: pNETs carry the worst prognosis of all NETs, particularly when hepatic metastasis are present. We try to actively treat all patients referred.

Aim(s): We aimed to determine survival at 1, 3 & 5 years for pNETs treated with modern aggressive multimodal management and compare outcomes to previously published data.

Materials and methods: Data was analysed from a single centre, prospective database. 95 of 396 NET patients were identified as pNETs. 3 patients had incomplete records and were excluded. Outcomes were analysed using Kaplan-Meier, with death as the endpoint.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Mayo D

Authors: Mayo D, Armstrong T, Cave J, Nolan L, Steadman B,

Keywords: pNET, multimodal, Neuroendocrine,